1-(5-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone

Catalog No. :
ACGVRX294
CAS No. :
94944-70-4
Molecular Formula :
C9H14N2O5
Molecular Weight :
230.22

IUPAC Name:1-(5-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethan-1-one

1-(5-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$610.00Login to see priceInquiryInquiry
250mg97%$1327.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(5-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone
IUPAC Name1-(5-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethan-1-one
Molecular FormulaC9H14N2O5
Molecular Weight230.22
SMILESCC(C1=NC=C([C@@H](O)[C@H](O)[C@H](O)CO)N1)=O
InChI KeyCQSIXFHVGKMLGQ-BWZBUEFSSA-N
Synonym1-[4-(1,2,3,4-TETRAHYDROXYBUTYL)-1H-IMIDAZOL-2-YL]ETHANONE;2-acetyl-4(5)-tetrahydroxybutylimidazole;2-ACETYL-4(5)-(1,2,3,4-TETRAHYDROXYBUTYL)-IMIDAZOLE (THI);2-Athbi;(1'R,2'S,3'R)-2-acetyl-4(5)-(1',2',3',4'-tetrahydroxy-1'-butyl)imidazole;Ethanone, 1-(4-(1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)-, (1R-(1R*,2S*,3R*))-;2-Acetyl-5-tetrahydroxybutyl Imidazole;Ethanone, 1-[5-[(1R,2S,3R)-1,2,3,4-tetrahydroxybutyl]-1H-iMidazol-2-yl]-
CAS No.94944-70-4
PubChem CID108037

Synthetic Route by SureRoute

1. ACGVRX294 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTAXY258 route compound structure diagram
    ACTAXY25839002-30-7 In Stock
  4. Then
  5. ACGVRX294 route product structure diagram
    ACGVRX29494944-70-4
Inquiry

2. ACGVRX294 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGVRX294 route product structure diagram
    ACGVRX29494944-70-4
Inquiry

Comments (0)